ライフサイエンスコーパス: heterologous immunity

1 pneumonia virus of mice, a property known as heterologous immunity.

2 rity of transplant recipients as a result of heterologous immunity.

3 hogenesis of infection by a process known as heterologous immunity.

4 itope cross-reactivity likely contributes to heterologous immunity.

5 uence disease outcome through the process of heterologous immunity.

6 rms of beneficial and detrimental effects of heterologous immunity.

7 the memory pool in patterns consistent with heterologous immunity.

8 Because B cells have been shown to promote heterologous immunity against respiratory virus pathogen

9 ceptor, was required in mediating protective heterologous immunity against VV.

10 between viruses can play roles in protective heterologous immunity and damaging immunopathology.

11 in clonal dominance, may be a consequence of heterologous immunity and lead to viral escape.

12 rtoires is brought about under conditions of heterologous immunity and might have important consequen

13 s are dispensable for Lactobacillus-mediated heterologous immunity and were not crucial for promoting

14 This is termed "heterologous immunity" and has not been assessed previou

15 Heterologous immunity associated with cross-reactive T-c

16 y therefore demonstrates CD4 T-cell-mediated heterologous immunity between a bacterium and virus.

17 ing a profound private specificity effect in heterologous immunity between these two viruses.

18 Examples of heterologous immunity between unrelated viruses and allo

19 the development of allosensitization through heterologous immunity, but the relationship between BK v

20 ings have direct implications for allogeneic heterologous immunity by demonstrating that despite a lo

21 pe (GLCTLVAML), that, under some conditions, heterologous immunity can lead to a significant broadeni

22 Heterologous immunity can shape outcome of infections an

23 re associated with protective homologous and heterologous immunity during ehrlichial infection.

24 peptide-MHC, the role of TCR affinity during heterologous immunity has not been explored.

25 ells between different viral peptides, i.e., heterologous immunity, has been well characterized.

26 blockade could surmount the barrier posed by heterologous immunity in a fully allogeneic murine trans

27 at cross-reactive T cells mediate protective heterologous immunity in mice.

28 This study extends our understanding of heterologous immunity in the context of persistent viral

29 Heterologous immunity induced two patterns of disease ou

30 We used an established model of heterologous immunity involving sequential infection of

31 -induced immunopathology under conditions of heterologous immunity is a function of the private speci

32 Heterologous immunity is recognized as a significant bar

33 This phenomenon, known as heterologous immunity, is dependent on the sequence of i

34 Thus, heterologous immunity may help explain why treatment of

35 Mimicking heterologous immunity may provide a means of enhancing b

36 ties of T-cell responses under conditions of heterologous immunity occur and have been linked to the

37 For the first time, our results illustrate heterologous immunity of virus-infected animals toward a

38 Heterologous immunity refers to a process in which a res

39 onstrated that homeostatic proliferation and heterologous immunity represent two naturally occurring

40 Heterologous immunity thus occurs between many viruses,

41 tivity with other antigens and play roles in heterologous immunity upon encounter with another pathog

42 A potent role for memory CD8+ T cells in heterologous immunity was shown with a respiratory mucos

43 Surprisingly, this heterologous immunity was superior to homologous immunit

44 -immune C57BL/6J mice through the process of heterologous immunity, we questioned whether TNF was req

45 function, which is particularly important in heterologous immunity, when microbe-specific T cells cro

46 mory T cells are generated by the process of heterologous immunity, whereby memory T cells arising in

47 also find some evidence that the preexisting heterologous immunity which reduced attack rates in adul

48 sed as a persistent infection model to study heterologous immunity with LCMV.